The Reading Frame
Published in

The Reading Frame

4 COVID Cell Therapies and the Companies That Are Making Them

Photo by Miguel Á. Padriñán from Pexels

The COVID-19 pandemic is one of modern medicine’s greatest challenges with 20 million (and counting) confirmed cases worldwide. Drugs in development to treat infections span small molecules, vaccines, and antibody-based therapies. Apart from these modalities, scientists are also using regenerative medicine paradigms as inspiration for new cell-based therapies to combat COVID-19.




The Reading Frame highlights breakthroughs at the leading edge of science, technology, and innovation.

Recommended from Medium

Rough sea ahead.

What Everyone’s Getting Wrong About the Toilet Paper Shortage

“Supertasters” Might Be Protected Against COVID-19

COVID: Beginning of the End

Life During Quarantine 11: Planes, Trains, and Automobiles.

This Is What Living With the Virus Would Have Meant

No More Jabs For Me — Why I now choose Natural Immunity

Corona Diary (November 17–23)

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
River D'Almeida, Ph.D

River D'Almeida, Ph.D

Follow me for bite-sized stories on the latest discoveries and innovations in biomedical research.

More from Medium

Cancer-Killing Jelly Stops Tumors From Coming Back

Coffee, Wine, Chocolate: Healthy or Not?

Why Mucus-Eating Bacteria Stimulate a Healthy Gut

How to Lower Your Risk of Alzheimer’s Disease